drugset / Trial / NCT00606489
Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study of Caldolor administered to hospitalized adult and pediatric burn patients is to determine the efficacy of Caldolor on reducing fever when compared to placebo when administered every 6 hours for at least 24 hours.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | 10 mg/kg | Intravenous |
| Subject | Ibuprofen | Small molecule | 800 mg | Intravenous |
Indications
No indication recorded.